Vironexis

Siren Biotechnology

The company develops adeno-associated virus immuno-gene therapies to treat solid tumour cancers for healthcare providers and patients.

IconOVir

The company develops engineered oncolytic virus therapies to treat patients with solid tumours.

Oncolytic virus therapies

This clinical-stage biotechnology company develops engineered oncolytic virus therapies for cancer patients to destroy tumours and stimulate the immune system.

Abalos Therapeutics

This company develops arenavirus-based immuno-virotherapies to treat solid tumours and metastases for patients with cancer.

Vyriad

The company develops engineered virus platforms and genetic therapies for pharmaceutical partners and medical institutions to treat cancers and other genetic diseases.

Theolytics

The company develops oncolytic viral immunotherapies for patients with solid tumours.

Vivere Oncotherapies

This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.

Stratosvir

This company develops viral immunotherapies for late-stage cancer patients to target solid tumours through systemic delivery and immune system activation.